FindTrial
Sign In

Utilities of small molecular metabolites for diagnosis and prognostic prediction in diffuse large B-cell lymphoma

Utilities of small molecular metabolites for diagnosis and prognostic prediction in diffuse large B-cell lymphoma

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100041744
Enrollment
Unknown
Registered
2021-01-03
Start date
2021-02-28
Completion date
Unknown
Last updated
2021-03-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lymphoma

Interventions

Training and validation group:chemotherapy

Sponsors

Department of Hematology, the First Hospital affiliated to Zhejiang University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1.Age older than 14 years. 2.Admitted to our hospital and diagnosed with diffuse large B-cell lymphoma from May 2014 to Dec 2020. 3.Blood stored at our biobank.

Exclusion criteria

Exclusion criteria: 1.Who had HIV disease. 2.Clinical information related to diagnosis and treatment response was unavailable. 3.Who complicated by another cancer. 4.Pregnancy with lymphoma. 5.Who had some medical conditions inappropriate for the study and affected to follow up,the condiction was determined by the researchers.

Design outcomes

Primary

MeasureTime frame
Progress-free survival;—

Secondary

MeasureTime frame
Treatment response;Overall survival;—

Countries

China

Contacts

Public ContactJie Jin

The First Hospital affiliated to Zhejiang University School of Medicine

jiej0503@zju.edu.cn+86 571-87236898

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026